Search research articles
Contact Us
Filters
Showing results (371-380 of 432) with videos related to
Page
of 44
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretation
Ana C Chang-Gonzalez, Eric W Bell, Carlos G Vanoye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> Inhibitors
Sarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Science Advances
|
September 15, 2016
Structural basis for KCNE3 modulation of potassium recycling in epithelia
Brett M Kroncke, Wade D Van Horn, Jarrod Smith, et al.
Nature Communications
|
September 19, 2025
Transient ligand contacts of the intrinsically disordered N-terminus of neuropeptide Y<sub>2</sub> receptor regulate arrestin-3 recruitment
Anette Kaiser, Juan C Rojas Echeverri, Asat Baischew, et al.
Science (New York, N.Y.)
|
November 16, 2023
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly
Xiaojun Shi, Ryan Lingerak, Cameron J Herting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2019
On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation
Benjamin P Brown, Yun-Kai Zhang, David Westover, et al.
Plos One
|
May 15, 2013
Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore
Mohammed S Aiyegbo, Gopal Sapparapu, Benjamin W Spiller, et al.
Iscience
|
August 19, 2022
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine
Despoina Aslanoglou, Suzanne Bertera, Laura Friggeri, et al.
The Journal of Clinical Investigation
|
May 19, 2015
Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth
Jordan R Willis, Gopal Sapparapu, Sasha Murrell, et al.
Cell Host & Microbe
|
January 12, 2018
The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding
Liam B King, Marnie L Fusco, Andrew I Flyak, et al.
Page
of 44
Search research articles
Search
Showing results (371-380 of 432) with videos related to
Sort By:
Page
of 44
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretation
Ana C Chang-Gonzalez, Eric W Bell, Carlos G Vanoye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> Inhibitors
Sarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Science Advances
|
September 15, 2016
Structural basis for KCNE3 modulation of potassium recycling in epithelia
Brett M Kroncke, Wade D Van Horn, Jarrod Smith, et al.
Nature Communications
|
September 19, 2025
Transient ligand contacts of the intrinsically disordered N-terminus of neuropeptide Y<sub>2</sub> receptor regulate arrestin-3 recruitment
Anette Kaiser, Juan C Rojas Echeverri, Asat Baischew, et al.
Science (New York, N.Y.)
|
November 16, 2023
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly
Xiaojun Shi, Ryan Lingerak, Cameron J Herting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2019
On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation
Benjamin P Brown, Yun-Kai Zhang, David Westover, et al.
Plos One
|
May 15, 2013
Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore
Mohammed S Aiyegbo, Gopal Sapparapu, Benjamin W Spiller, et al.
Iscience
|
August 19, 2022
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine
Despoina Aslanoglou, Suzanne Bertera, Laura Friggeri, et al.
The Journal of Clinical Investigation
|
May 19, 2015
Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth
Jordan R Willis, Gopal Sapparapu, Sasha Murrell, et al.
Cell Host & Microbe
|
January 12, 2018
The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding
Liam B King, Marnie L Fusco, Andrew I Flyak, et al.
Page
of 44